S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.0085 SEK Market Closed
Market Cap: 7.1m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

S2Medical AB (publ)
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

S2Medical AB (publ)
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
S2Medical AB (publ)
STO:S2M
Total Current Liabilities
kr7.5m
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Total Current Liabilities
kr47.3m
CAGR 3-Years
-12%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Total Current Liabilities
kr150.8m
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
25%
D
Doxa AB
STO:DOXA
Total Current Liabilities
kr228.1m
CAGR 3-Years
182%
CAGR 5-Years
126%
CAGR 10-Years
58%
Bactiguard Holding AB
STO:BACTI B
Total Current Liabilities
kr261.4m
CAGR 3-Years
94%
CAGR 5-Years
36%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Total Current Liabilities
€93.6m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

S2Medical AB (publ)
Glance View

Market Cap
7.1m SEK
Industry
Health Care

S2Medical AB engages in research and development in biotechnology. The company is headquartered in Linkoping, Ostergotland. The company went IPO on 2018-11-28. The firm focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The firm's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The firm is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.

S2M Intrinsic Value
0.0322 SEK
Undervaluation 74%
Intrinsic Value
Price
S

See Also

What is S2Medical AB (publ)'s Total Current Liabilities?
Total Current Liabilities
7.5m SEK

Based on the financial report for Jun 30, 2024, S2Medical AB (publ)'s Total Current Liabilities amounts to 7.5m SEK.

What is S2Medical AB (publ)'s Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
16%

Over the last year, the Total Current Liabilities growth was -74%. The average annual Total Current Liabilities growth rates for S2Medical AB (publ) have been 15% over the past three years , 16% over the past five years .

Back to Top